NASDAQ:XERS

Xeris Pharmaceuticals Stock Predictions

etoro logo Buy XERS
*Your capital is at risk
$5.89
-0.110 (-1.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

XERS Prediction Chart

XERS Predictions History

Latest community submissions for XERS.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 9, 2026 $8.02 -1.37% $7.93 V 98.88% 2
Jan 9, 2026 Bullish $7.93 V 0
Nov 10, 2025 $7.65 +2.95% $7.72 V 99.08% 2
Nov 10, 2025 $7.57 +1.84% $7.72 V 98.02% 1
Nov 10, 2025 $9.99 +29.57% $7.72 V 70.60% 1
Nov 3, 2025 $9.55 -1.58% $9.90 X 96.43% 0
Nov 3, 2025 $9.60 -0.99% $9.90 X 97.01% 0
Nov 3, 2025 Bullish $9.90 V 1
Oct 20, 2025 $9.09 -1.64% $9.34 X 97.30% 0
Oct 20, 2025 $9.15 -1.03% $9.34 X 97.91% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XERS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT XERIS PHARMACEUTICALS INC
Xeris Pharmaceuticals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE